Enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties... Click here to see why

In one of the first efforts of its kind, UCLA researchers have taken mammalian genome maps, including human maps, one step further by showing not just the order in which genes fall in the genome but which genes actually interact. ... Read more


The UCI study, led by Aileen Anderson and Brian Cummings of the Sue and Bill Gross Stem Cell Research Center, is significant because the therapy can restore mobility during the later chronic phase, the period after spinal cord injury in which inflammation has stabilized and recovery has reached a plateau. There are no drug treatments to help restore function in such cases... Read more


Hansma is a co-author of a new study published in the Journal of Bone and Mineral Research. In the study, "Microindentation for in vivo Measurement of Bone Tissue Mechanical Properties in Humans," Hansma and his co-authors say they have validated the RPI as a new tool for measuring the strength and quality of bones by using live human test subjects.... Read more

LoneStar Heart, Inc. is an early-stage biomedical company developing new therapies to preserve and restore adequate heart function in patients with Congestive Heart Failure (CHF)... Learn more.


The company's product line includes three types of EtO sterilizers (Anprolene, EOGas and Sterijet), with their associated chemical and biological sterilization monitors... Learn more

The Beverly Hills-based subsidiary of Cascade Technologies will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule. The device incorporates new advances in component technologies (optics, cameras, displays, embedded computers and software), as well as experience derived from previous prototypes developed under federal funding and tested in the clinic. The spectral range covered is also extended, now ranging from 385 nm to 920 nm... Read more

The San Clemente-based VertiFlex sells its Silverbolt product portfolio and related assets to Exactech, Inc. "Strategically, this asset sale is very important for VertiFlex, in that it allows us to further focus on our Superion Interspinous Spacer programs," said Earl R. Fender, President & Chief Executive Officer of VertiFlex, Inc... Read more

The company will supply its novel, ultra rapid acting insulin AFREZZA (insulin human [rDNA origin]) for use in a study being conducted by the Juvenile Diabetes Research Foundation (JDRF) as part of its Artificial Pancreas Project. The planned two-year study in patients with type 1 diabetes will leverage the unique rapid action of AFREZZA for use in a closed-loop blood sugar monitoring and insulin delivery system, termed the "artificial pancreas" by the JDRF. The study will be managed in conjunction with the Sansum Diabetes Research Institute and the University of California, Santa ... Read more

Due to China's policy on enhancing fast track development of the bio-industry and as well as health reform entailing national healthcare service by 2020, China's medical device market is expected to grow to US$20.6 billion in 2010 and is fast becoming one of the world's largest markets. The International Medical Device, Equipment and Supplies tradeshow will be held in Hong Kong 3-5 November 2010. Allied Intrade Inc. will be bringing a private business delegation to Hong Kong to attend this trade show, industry networking events, pre-arrange private business collaboration meetings, exclusive tour the Medical Device Industrial City in Dongguan and the Hong Kong Science and Technology Park. For further information, please contact Caroline Cheung at caroline@alliedintrade.com

SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio